Harnessing Non-Antibiotic Strategies to Counter Multidrug-Resistant Clinical Pathogens with Special Reference to Antimicrobial Peptides and Their Coatings

MDPI 2025-01-01

Antimicrobial resistance is a critical global challenge in the 21st century, validating Sir Alexander Fleming’s warning about the misuse of antibiotics leading to resistant microbes. With a dwindling arsenal of effective antibiotics, it is imperative to concentrate on alternative antimicrobial strategies. Previous studies have not comprehensively discussed the advantages and limitations of various strategies, including bacteriophage therapy, probiotics, immunotherapies, photodynamic therapy, essential oils, nanoparticles and antimicrobial peptides (AMPs) within a single review. This review addresses that gap by providing an overview of these various non-antibiotic antimicrobial strategies, highlighting their pros and cons, with a particular emphasis on antimicrobial peptides (AMPs). We explore the mechanism of action of AMPs against bacteria, viruses, fungi and parasites. While these peptides hold significant promise, their application in mainstream drug development is hindered by challenges such as low bioavailability and potential toxicity. However, advancements in peptide engineering and chemical modifications offer solutions to enhance their clinical utility. Additionally, this review presents updates on strategies aimed at improving the cost, stability and selective toxicity of AMPs through the development of peptidomimetics. These molecules have demonstrated effective activity against a broad range of pathogens, making them valuable candidates for integration into surface coatings to prevent device-associated infections. Furthermore, we discuss various approaches for attaching and functionalising these peptides on surfaces. Finally, we recommend comprehensive in vivo studies to evaluate the efficacy of AMPs and their mimetics, investigate their synergistic combinations with other molecules and assess their potential as coatings for medical devices.

3214 Pharmacology and Pharmaceutical Sciences; 32 Biomedical and Clinical Sciences; Emerging Infectious Diseases; Infectious Diseases; Biotechnology; Biodefense; Antimicrobial Resistance; 5.1 Pharmaceuticals; Infection; antimicrobial coating; antimicrobial peptide; peptide engineering; peptidomimetics; anzsrc-for: 3214 Pharmacology and Pharmaceutical Sciences; anzsrc-for: 32 Biomedical and Clinical Sciences; journal article; http://purl.org/coar/resource_type/c_6501

Open access content. Open access content
open access
https://purl.org/coar/access_right/c_abf2
CC-BY
https://creativecommons.org/licenses/by/4.0
CC BY
https://creativecommons.org/licenses/by/4.0
free_to_read

application/pdf

LJ1 oai:unsworks.library.unsw.edu.au:1959.4/103843
1503085850

UNIV OF NEW S WALES
From OAIster®, provided by the OCLC Cooperative.

edsoai.on1503085850